United States Of America Ex Rel Dr Todd Scarbrough V Alabama Cancer

Court Listener

Automated Summary

Key Facts

Dr. Todd Scarbrough alleges Alabama Cancer Care, LLC (ACC) and physicians Shelby Sanford, Ashvini Sengar, and Aasim Sehbai defrauded Medicare through three schemes: (1) billing for radiation treatment management (CPT 77427) without required in-person patient visits, (2) billing for CT diagnostic services (CPT 77014) not reviewed by physicians and using forged documentation, and (3) billing for IMRT services (CPT 77301, 77338, G6015, G6016) without proper quality assurance testing. The court dismissed claims against Sengar and Sehbai for CPT 77427 due to public disclosure and pleading deficiencies but allowed claims against Sanford, ACC, and others for CPT 77014 and IMRT services to proceed.

Issues

  • The court addressed whether Dr. Scarbrough's amended complaint sufficiently alleged that Dr. Sanford and Alabama Cancer Care, LLC (ACC) submitted false claims for radiation treatment management under CPT Code 77427 by failing to meet face-to-face encounter requirements and whether these allegations satisfied Rule 9(b)'s particularity standards for fraud claims.
  • The court considered if the plaintiffs' allegations that ACC and Sanford submitted false IMRT service claims (CPT 77301, 77338, G6015, G6016) from 2016-2020 were plausible, given their failure to perform required patient-specific QA testing using phantoms or dosimetry devices, as mandated by Medicare and industry standards.
  • The court assessed if ACC's claims for CT diagnostic services under Code 77014 were fraudulent due to unreviewed CT images and forged physician signatures, including allegations that ACC used relator's and Dr. Harris's NPI numbers without their knowledge or authorization.
  • The court evaluated if the relator's allegations against Dr. Sengar for billing Medicare under CPT 77427 as a non-radiation oncologist were publicly disclosed in media or federal records, and whether Scarbrough qualified as an original source to avoid dismissal under the FCA's public disclosure bar.

Holdings

  • The court grants ACC's motion to dismiss the CT diagnostic services claims (Code 77014) billed under Harris's NPI number with prejudice. Scarbrough's allegations about Harris's patient J.W. lack specific factual support for how ACC billed these claims, leading to dismissal under Rule 9(b).
  • The court grants Sengar's motion to dismiss the radiation treatment management claims (Code 77427) due to the public disclosure bar. Sengar's status as a medical oncologist billing for Code 77427 services was publicly available on ACC's website, CMS, and news media. Scarbrough's allegations lack independent knowledge and do not materially add to the disclosed information.
  • The court denies Sanford's motion to dismiss the radiation treatment management claims (Code 77427) because Scarbrough's allegations include specific factual details showing Sanford never saw patients as required for billing, supported by Medicare billing data for hundreds of claims from 2016 to 2020.
  • The court dismisses with prejudice the IMRT claims against Sengar. Scarbrough explicitly abandoned these claims in his response brief, and no allegations were made against Sengar for IMRT services.
  • The court denies ACC's motion to dismiss the CT diagnostic services claims (Code 77014) billed under Scarbrough's NPI number. Scarbrough alleges ACC technicians forged his signature on treatment records, and billing data shows hundreds of claims from 2018 to 2020. The court finds these allegations plausibly suggest ACC's knowledge of the fraud.
  • The court grants ACC's motion to dismiss the Sehbai-related radiation treatment management claims (Code 77427) with prejudice. Scarbrough's knowledge of Sehbai's conduct is limited to his absence from the Anniston office, and there is insufficient evidence to link CMS billing data to fraudulent claims.
  • The court denies ACC and Sanford's motion to dismiss the IMRT services claims (Codes 77301, 77338, G6015, G6016). Scarbrough's amended complaint plausibly alleges ACC abandoned patient-specific QA procedures in 2016, violating Medicare standards. The court rejects arguments that LCD L39553 and practice guidelines lack legal force at this stage.

Remedies

  • The court denies the motion to dismiss the intensity modulated radiation therapy (IMRT) services claims against ACC and Dr. Shelby Sanford.
  • The court dismisses with prejudice the radiation treatment management (Code 77427) allegations against Dr. Ashvini Sengar and Dr. Aasim Sehbai due to insufficient pleadings and public disclosure bar.
  • The court dismisses with prejudice the Image Guided Radiation Therapy (Code 77014) allegations related to billing under Dr. Anna Harris's NPI number for lack of specific factual support.
  • The court dismisses with prejudice all IMRT services claims against Dr. Ashvini Sengar as the relator does not seek to prosecute them.
  • The court denies the motion to dismiss the Sanford-related radiation treatment management claims against Alabama Cancer Care, LLC (ACC) and Dr. Shelby Sanford.
  • The court denies the motion to dismiss the Image Guided Radiation Therapy (Code 77014) claims against ACC related to billing under Dr. Scarbrough's NPI number.

Legal Principles

  • The court applied Rule 9(b) of the Federal Rules of Civil Procedure, which requires fraud allegations to be pleaded with particularity, including specific details about the time, place, and substance of the alleged fraud. Additionally, the court enforced the False Claims Act's public disclosure bar, which mandates dismissal of claims if substantially the same allegations were publicly disclosed unless the relator is an original source.
  • The court evaluated the scienter requirement under the False Claims Act, determining that claims can be dismissed if the defendant acted with actual knowledge, deliberate ignorance, or reckless disregard. The court also reaffirmed that factual disputes do not justify dismissal at the pleading stage, emphasizing that well-pleaded allegations must be accepted as true.

Precedent Name

  • United States ex rel. McKoy v. Atlanta Primary Care Peachtree, P.C.
  • Ashcroft v. Iqbal
  • United States ex rel. Edler v. Escambia Cnty.
  • United States ex rel. Jacobs v. JP Morgan Chase Bank, N.A.
  • United States ex rel. Clausen v. Lab. Corp. of Am.
  • United States ex rel. Osheroff v. Humana Inc.
  • United States ex rel. Ondis v. City of Woodstock
  • United States ex rel. Vargas v. Lincare, Inc.
  • United States ex rel. Schutte v. Supervalu Inc.

Cited Statute

  • False Claims Act (31 U.S.C. § 3729)
  • False Claims Act (31 U.S.C. § 3730)
  • Social Security Act (42 U.S.C. § 1395y)
  • Federal Rules of Civil Procedure (Rule 8(a))
  • Federal Rules of Civil Procedure (Rule 9(b))
  • Federal Rules of Civil Procedure (Rule 12(b)(6))

Judge Name

Coreyl L. Maze

Passage Text

  • The court DENIES Sanford's motion to dismiss the radiation treatment management claims because Scarbrough's allegations provide sufficient indicia of reliability, including specific billing data and assertions that Sanford never saw patients at multiple ACC offices.
  • The court DENIES dismissal of IMRT claims against ACC and Sanford, finding that their software-only QA verification process plausibly fails to meet Medicare's safety standards and that they acted with deliberate ignorance or reckless disregard.
  • The court GRANTS Sengar's motion to dismiss radiation treatment management claims under the public disclosure bar, finding Scarbrough's knowledge of Sengar's non-radiation oncology status not independent of publicly available information.